J. B. Chemicals & Pharmaceuticals Limited
JBCHEPHARM
Classifica tra le azioni
#3889
J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai,... J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai, India, in 1976, specializes in the development, production, and global distribution of diverse pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. Among its prominent product offerings are Cilnidipine, Ranitidine, and Metronidazole. Beyond its own brands, the company extends comprehensive contract manufacturing services, covering an extensive spectrum of dosage forms such as tablets, various lozenge types, injectables, gels, creams, ointments, liquid herbal syrups, and capsules. The firm further contributes to diagnostic medicine by supplying contrast agents for advanced imaging techniques like X-ray, MRI, and ultrasound. Its therapeutic expertise encompasses a broad range of medical fields, including gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance.
Prezzo delle azioni
$26.58
Ultima sincronizzazione: 2026-07-23
Capitalizzazione di mercato
$4.24B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
38.14%
Paese
IN
Scambia J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Categoria
Healthcare
Rapporto P/S per J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Rapporto P/S al October 2026 TTM: 9.35
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di J. B. Chemicals & Pharmaceuticals Limited, il rapporto P/S attuale (TTM) è 9.35. Alla fine del 2024, era pari a 7.54.
Storico del rapporto P/S per J. B. Chemicals & Pharmaceuticals Limited da 2005 a 2026
Rapporto P/S alla fine di ogni anno
| Anno | Rapporto P/S | Cambia |
|---|---|---|
| 2026 (TTM) | 9.35 | 48.93% |
| 2025 | 6.28 | -16.71% |
| 2024 | 7.54 | 53.78% |
| 2023 | 4.90 | -2.38% |
| 2022 | 5.02 | 3.84% |
| 2021 | 4.84 | 110.26% |
| 2020 | 2.30 | 21.87% |
| 2019 | 1.89 | -0.31% |
| 2018 | 1.89 | -15.47% |
| 2017 | 2.24 | 23.70% |
| 2016 | 1.81 | 12.32% |
| 2015 | 1.61 | 39.47% |
| 2014 | 1.16 | 40.76% |
| 2013 | 0.82 | 27.61% |
| 2012 | 0.64 | -51.50% |
| 2011 | 1.33 | 64.39% |
| 2010 | 0.81 | 88.62% |
| 2009 | 0.43 | -42.68% |
| 2008 | 0.75 | -40.69% |
| 2007 | 1.26 | -36.45% |
| 2006 | 1.98 | 7.09% |
| 2005 | 1.85 | 0.00% |
Rapporto P/S per aziende simili o concorrenti
| Azienda | Rapporto P/S | Differenza del rapporto P/S | Il paese |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -24.54% |
IN
|
